Therapeutic Nuclear Medicines Market

Chapter 1 Therapeutic Nuclear Medicines Market Overview

1.1 Therapeutic Nuclear Medicines Definition

1.2 Global Therapeutic Nuclear Medicines Market Size Status and Outlook (2019-2032)

1.3 Global Therapeutic Nuclear Medicines Market Size Comparison by Region (2019-2032)

1.4 Global Therapeutic Nuclear Medicines Market Size Comparison by Type (2019-2032)

1.5 Global Therapeutic Nuclear Medicines Market Size Comparison by Application (2019-2032)

1.6 Global Therapeutic Nuclear Medicines Market Size Comparison by Sales Channel (2019-2032)

1.7 Therapeutic Nuclear Medicines Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Therapeutic Nuclear Medicines Market Snapshot

2.2 Global Therapeutic Nuclear Medicines Market Volume & Revenue 2019-2025

2.3 Global Therapeutic Nuclear Medicines Market Differential Growth Potential Analysis by Type, 2019-2032 (USD Million)

2.4 Global Therapeutic Nuclear Medicines Market Differential Growth Potential Analysis by Application, 2019-2032 (USD Million)

2.5 Global Therapeutic Nuclear Medicines Market Differential Growth Potential Analysis by Sales Channels, 2019-2032 (USD Million)

2.6 Global Therapeutic Nuclear Medicines Market Differential Growth Potential Analysis by Region, 2019-2032 (USD Million)

Chapter 3 Therapeutic Nuclear Medicines Market Segment Analysis by Player

3.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Player (2023-2025)

3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Player (2023-2025)

3.3 Global Therapeutic Nuclear Medicines Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Therapeutic Nuclear Medicines Market Segment Analysis by Type

4.1 Global Therapeutic Nuclear Medicines Market by Type

4.1.1 Radium-223

4.1.2 Lutetium-177

4.1.3 Iodine-131

4.1.4 Other

4.2 Global Therapeutic Nuclear Medicines Sales and Market Share by Type (2019-2025)

4.3 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2019-2025)

4.4 Global Therapeutic Nuclear Medicines Average Price by Type (2019-2025)

4.5 Leading Players of Therapeutic Nuclear Medicines by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Therapeutic Nuclear Medicines Market Segment Analysis by Application

5.1 Global Therapeutic Nuclear Medicines Market by Application

5.1.1 Thyroid

5.1.2 Bone Metastasis

5.1.3 Lymphoma

5.1.4 Other

5.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Therapeutic Nuclear Medicines by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Therapeutic Nuclear Medicines Market Segment Analysis by Sales Channel

6.1 Global Therapeutic Nuclear Medicines Market by Sales Channel

6.1.1 Global Therapeutic Nuclear Medicines Market, by Direct Channel Market Analysis 2019-2032 (USD Million)

6.1.2 Global Therapeutic Nuclear Medicines Market, by Distribution Channel Market Analysis 2019-2032 (USD Million)

6.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Therapeutic Nuclear Medicines by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Therapeutic Nuclear Medicines Market Segment Analysis by Region

7.1 Global Therapeutic Nuclear Medicines Market Size and CAGR by Region (2019-2032)

7.2 Global Therapeutic Nuclear Medicines Sales and Market Share by Region (2019-2025)

7.3 Global Therapeutic Nuclear Medicines Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Therapeutic Nuclear Medicines Market Share by Type

7.4.3 North America Therapeutic Nuclear Medicines Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Therapeutic Nuclear Medicines Market Share by Type

7.5.3 Europe Therapeutic Nuclear Medicines Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Therapeutic Nuclear Medicines Market Share by Type

7.6.3 Asia-Pacific Therapeutic Nuclear Medicines Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Therapeutic Nuclear Medicines Market Share by Type

7.7.3 South America Therapeutic Nuclear Medicines Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Therapeutic Nuclear Medicines Market Share by Type

7.8.3 Middle East & Africa Therapeutic Nuclear Medicines Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.8.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Therapeutic Nuclear Medicines Players

8.1 Novartis AG

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Bayer

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 China Isotope & Radiation

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Q BioMed

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Curium Pharmaceuticals

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Jubilant DraxImage

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Dongcheng

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Lantheus

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Acrotech Biopharma.

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Progenics Pharmaceuticals

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 International Isotopes

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 Others

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Therapeutic Nuclear Medicines

9.1 Industrial Chain of Therapeutic Nuclear Medicines

9.2 Upstream of Therapeutic Nuclear Medicines

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Therapeutic Nuclear Medicines

9.3.1 Leading Distributors/Dealers of Therapeutic Nuclear Medicines

9.3.2 Leading Consumers of Therapeutic Nuclear Medicines

Chapter 10. Global Therapeutic Nuclear Medicines Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Therapeutic Nuclear Medicines Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Therapeutic Nuclear Medicines Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Therapeutic Nuclear Medicines (2026-2032)

11.1 Global Therapeutic Nuclear Medicines Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Therapeutic Nuclear Medicines Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Therapeutic Nuclear Medicines Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Therapeutic Nuclear Medicines Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Therapeutic Nuclear Medicines Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Therapeutic Nuclear Medicines Import-Export, 2019-2025

12.2 Europe Therapeutic Nuclear Medicines Import-Export, 2019-2025

12.3 Asia Pacific Therapeutic Nuclear Medicines Import-Export, 2019-2025

12.4 South America Therapeutic Nuclear Medicines Import-Export, 2019-2025

12.5 Middle East & Africa Therapeutic Nuclear Medicines Import-Export, 2019-2025

Chapter 13. Demand-Supply Gap Analysis (If Applicable)

13.1 North America Therapeutic Nuclear Medicines Demand-Supply, 2019-2025

13.2 Europe Therapeutic Nuclear Medicines Demand-Supply, 2019-2025

13.3 Asia Pacific Therapeutic Nuclear Medicines Demand-Supply, 2019-2025

13.4 South America Therapeutic Nuclear Medicines Demand-Supply, 2019-2025

13.5 Middle East & Africa Therapeutic Nuclear Medicines Demand-Supply, 2019-2025

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources